identity of all markers if the child is a chimera and not a mosaic.
EARLY EMBRYOLOGY AND MOSAICISM
Before drawing a final conclusion we examined the plausibility of a mosaic origin in the early embryo. The two most economical hypotheses are shown in the figure.
An XXY zygote is postulated. Clearly, both XX and XY cell lines could not originate before the second cleavage division. Other hypotheses involving lagging or non-disjunction or both at later divisions of the embryo are also possible, but none would yield a cell population in which more than 50% of the cells were of the two types, XX and XY, unless, of course, differential proliferation of cells with different karyotypes occurred. We prefer to avoid such an assumption although it would favour our case.
Current views on the early embryology of both mouse and man are that only three or four cells in a mammalian blastocyst are selected as progenitors of the embryo proper. "' Thus it seems likely that precocious non-disjunctional events could produce karyotypically distinct lines present in the placenta or in the fetus but not necessarily in both. Demonstration of this can be seen in the papers of Kalousek and Dill" 1 and Simoni et al, 12 who found examples in man of chromosomal abnormalities confined to extraembryonic tissues. On the basis of the analyses of chromosomal polymorphisms and genetic markers, we therefore conclude that our XX/XY case is a mosaic rather than a chimera.
During the preparation of this paper C E Ford was visiting Professor at the University of Pavia. The authors are grateful to Dr Patricia Tippett for determining the blood groups and to Professor M Fraccaro for stimulating discussion. X ray of the chest indicated left ventricular hypertrophy and increased pulmonary vasculature. An echocardiogram showed an atrial septal defect of secondum origin. There was no evidence of a ventricular septal defect. ECG showed ectopic beats, probably of ventricular or junctional origin. The nature of the underlying cardiac lesion was thought to be cardiomyopathy. The patient has been reported to be progressing satisfactorily.
CYTOGENETIC FINDINGS 'I'he patient was referred for cytogenetic evaluation at 14 months owing to a general failure to thrive. Lymphocyte preparations were made according to the routine methotrexate method used in this laboratory.2 Chromosome 5 showed a small additional negative staining fraction of material at the end of the short arm (fig 2) . In order to discover the origins of this material, the parents, maternal grandparents, and an elder sib were also referred for cytogenetic analysis. Thus it was found that both the mother and sib carried an inverted chromosome 5 (pl5.3q35) with the terminal negative band of the long arm being relocated at the end of the short arm (fig 2) . It can, therefore, be assumed that the abnormal chromosome in the proband arose as a result of meiotic recombination, giving a product which carries the terminal negative band of the chromosome 5 long arm at both ends of the chromosome, and is missing a small piece of the chromosome 5 short arm. This product is described as rec (5) clinically distinguishable phenotypes could be identified according to the particular region of the long arm of chromosome 5 duplicated. The first syndrome, corresponding to the proximal duplication 5qll-*q22, and then described in only a single case,4
was not supported by the report of Gilgenkrantz et al. 5 The other syndromes correspond to duplications of 5q31 or 5q33--qter and that of 5q34-*qter. These latter syndromes shared most clinical features which were considered to be less severe in those patients with the smaller duplications.3
Passarge et at described three cases with duplication/deficiency and identified a distinct phenotype. They expressed the opinion that this phenotype was the result of duplication 5q33->qter rather than the chromosomal deficiency (8q23-*qter) also present.
These authors drew attention to the similar phenotype observed in two previous patients with duplication of 5q31--qter. Martin et al7 described a patient with pure duplication of 5q22-*q33 and noted the similarity of phenotypic findings to previously described patients with partial trisomy for the long arm of chromosome 5 .
The most common features of the reported patients (table 4) with partial trisomy 5q, almost all involving at least q35->qter, are growth and mental retardation, microcephaly, craniofacial dysmorphism including antimongoloid slant, strabismus, prominent nasal bridge, and low set dysplastic ears, brachydactyly or clinodactyly or both, and heart defect. Our case (dup 5q35-*qter) has all these apart from strabismus. It is not possible to state that the dysmorphism in our patient is less severe than in the patients with larger duplications of chromosome 5. We are doubtful that this combination of features constitutes a specific clinical syndrome, for each is a common manifestation of chromosome abnormality and the total pattern is not sufficiently distinctive. There seems to be no real justification, on present evidence, for recognising clinical subgroups corresponding to the particular region of the long arm of chromosome 5 
